Domov › Rak endometrija › Pennsylvania › Philadelphia

Klinične študije za Rak endometrija v Philadelphia, PA

28 študij za Rak endometrija išče udeležence na lokacijah v Philadelphia in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Vključevanje udeležencevFaza 3

Thomas Jefferson University Hospital, Philadelphia
Jefferson Torresdale Hospital, Philadelphia
Asplundh Cancer Pavilion, Willow Grove · 13 mi stran

Starost 18 in več · Ženske · Posodobljeno 5. okt. 2026 · NCT07198074

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Vključevanje udeležencevFaza 2

Pennsylvania Hospital, Philadelphia
Thomas Jefferson University Hospital, Philadelphia
Fox Chase Cancer Center, Philadelphia
in še 4

Vse starosti · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Vključevanje udeležencevFaza 1/2

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

Starost 12 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04585750

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

Vključevanje udeležencevFaza 1

NRG Oncology, Philadelphia
University of Pennsylvania/Abramson Cancer Center, Philadelphia
Thomas Jefferson University Hospital, Philadelphia

Starost 18 in več · Ženske · Posodobljeno 2. okt. 2026 · NCT05950464

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Vključevanje udeležencevFaza 1

Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia

Starost 19 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06586957

Study of AVZO-021 in Patients With Advanced Solid Tumors

Vključevanje udeležencevFaza 1/2

Avenzo Therapeutics Recruiting Site, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT05867251

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Vključevanje udeležencevFaza 2

UPMC Hillman Cancer Center - Part of Frick Hospital, Mount Pleasant · 8 mi stran

Starost 18 in več · Ženske · Posodobljeno 28. sep. 2026 · NCT05112601

DESTINY-PANTUMOUR04

Vključevanje udeležencevOpazovalna študija

Research Site, Philadelphia

Starost 18–130 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07124000

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Vključevanje udeležencevFaza 1

Research Site, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06218914

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Vključevanje udeležencevFaza 2

Thomas Jefferson University, Philadelphia
Lankenau Medical Center, Wynnewood · 7 mi stran
Asplundh Cancer Pavilion, Willow Grove · 13 mi stran
in še 1

Starost 18 in več · Ženske · Posodobljeno 24. sep. 2026 · NCT05640999

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

Vključevanje udeležencevFaza 1/2

Perelman School of Medicine at the University of Pennsylvania, Philadelphia

Starost 18 in več · Ženske · Posodobljeno 24. sep. 2026 · NCT04590326

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Vključevanje udeležencevFaza 3

Hospital of the University of Pennsylvania ( Site 5007), Philadelphia

Starost 18 in več · Ženske · Posodobljeno 17. sep. 2026 · NCT06952504

PROton Therapy for Post Surgical Treatment of GYNecologic Cancer

Vključevanje udeležencevFaza 2

University of Pennsylvania, Philadelphia

Starost 18 in več · Ženske · Posodobljeno 17. sep. 2026 · NCT05758688

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Vključevanje udeležencevOpazovalna študija

University of Pennsylvania, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT05059444

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Vključevanje udeležencevFaza 3

Research Site, Philadelphia

Starost 18 in več · Ženske · Posodobljeno 3. sep. 2026 · NCT06989112

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Vključevanje udeležencevFaza 1

Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07216105

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Vključevanje udeležencevFaza 1/2

Children's Hospital of Philadelphia, Philadelphia

12 Months – 30 Years · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT04851119

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Vključevanje udeležencevFaza 1

Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 21. avg. 2026 · NCT06774963

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Vključevanje udeležencevFaza 1/2

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT04104776

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

Vključevanje udeležencevFaza 1

SCRI - Sydney Kimmel Cancer Center - Jefferson Health, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT07470853

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Vključevanje udeležencevFaza 1

Normunity Investigational Site, Philadelphia
Normunity Investigational Site, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT07182149

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Vključevanje udeležencevFaza 1/2

University of Pennsylvania, Perelman School of Medicine, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT05919264

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Vključevanje udeležencevFaza 1/2

University of Pennsylvania / Abramson Cancer Center, Philadelphia
Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia

Starost 18 in več · Vsi spoli · Posodobljeno 30. jul. 2026 · NCT04657068